The association between Alu hypomethylation and the severity of hypertension.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 23 11 2021
accepted: 02 06 2022
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Epigenetic changes that cause genomic instability may be the basis of pathogenic processes of age-associated noncommunicable diseases (NCDs). Essential hypertension is one of the most common NCDs. Alu hypomethylation is an epigenetic event that is commonly found in elderly individuals. Epigenomic alterations are also found in age-associated NCDs such as osteoporosis and diabetes mellitus. Alu methylation prevents DNA from being damaged. Therefore, Alu hypomethylated DNA accumulates DNA damage and, as a result, causes organ function deterioration. Here, we report that Alu hypomethylation is a biomarker for essential hypertension. We investigated Alu methylation levels in white blood cells from normal controls, patients with prehypertension, and patients with hypertension. The hypertension group possessed the lowest Alu methylation level when classified by systolic blood pressure and diastolic blood pressure (P = 0.0002 and P = 0.0088, respectively). In the hypertension group, a higher diastolic blood pressure and a lower Alu methylation level were observed (r = -0.6278). Moreover, we found that changes in Alu hypomethylation in the four years of follow-up in the same person were directly correlated with increased diastolic blood pressure. Similar to other age-associated NCDs, Alu hypomethylation is found in essential hypertension and is directly correlated with severity, particularly with diastolic blood pressure. Therefore, Alu hypomethylation may be linked with the molecular pathogenesis of high blood pressure and can be used for monitoring the clinical outcome of this disease.

Identifiants

pubmed: 35802708
doi: 10.1371/journal.pone.0270004
pii: PONE-D-21-37190
pmc: PMC9269909
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0270004

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

World J Cardiol. 2014 Jun 26;6(6):353-66
pubmed: 24976907
Hypertension. 2019 Oct;74(4):826-832
pubmed: 31476911
Circ Res. 2021 Apr 2;128(7):993-1020
pubmed: 33793335
Hypertension. 2021 Feb;77(2):284-295
pubmed: 33390048
Int J Mol Sci. 2018 Apr 12;19(4):
pubmed: 29649151
Physiol Genomics. 2010 Apr 1;41(2):194-200
pubmed: 20145203
Clin Epigenetics. 2011 Aug 1;2(2):299-314
pubmed: 21927626
Hypertension. 2005 Sep;46(3):454-62
pubmed: 16103272
Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):593-601
pubmed: 15702613
BMC Med Genomics. 2021 Feb 27;14(1):59
pubmed: 33639933
Physiol Genomics. 2017 Nov 1;49(11):630-652
pubmed: 28887369
Int J Mol Sci. 2018 Feb 28;19(3):
pubmed: 29495593
Cancer Prev Res (Phila). 2016 Jul;9(7):534-46
pubmed: 26883721
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
J Am Coll Cardiol. 2020 Jan 7;75(1):29-39
pubmed: 31918832
J Hypertens. 1998 May;16(5):577-83
pubmed: 9797168
Biomed Res Int. 2014;2014:784706
pubmed: 25243180
Front Cell Dev Biol. 2021 Jun 28;9:699374
pubmed: 34262910
Hypertension. 2021 Apr;77(4):1223-1233
pubmed: 33583201
PLoS One. 2020 Jan 30;15(1):e0227728
pubmed: 31999706
J Hum Genet. 2015 Jul;60(7):349-55
pubmed: 25833468
Endocrinol Diabetes Metab. 2020 Nov 04;4(1):e00196
pubmed: 33532623
J Biomed Sci. 2021 Aug 7;28(1):58
pubmed: 34364371
Int J Cardiol. 2021 Jan 1;322:233-239
pubmed: 32920065
J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):17-29
pubmed: 17170603
Biomed Res Int. 2015;2015:421747
pubmed: 26448937
Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):307-9
pubmed: 17696752
Med Sci Monit. 2010 Mar;16(3):CR149-155
pubmed: 20190686
J Hum Hypertens. 2019 Oct;33(10):703-715
pubmed: 31346255
Clin Chim Acta. 2011 Jan 30;412(3-4):314-21
pubmed: 21078311
Int J Mol Sci. 2016 Mar 25;17(4):451
pubmed: 27023534
Clin Epigenetics. 2017 Aug 31;9:93
pubmed: 28883893
BMC Clin Pathol. 2013 Mar 19;13:10
pubmed: 23510117
BMJ. 2009 Jul 10;339:b2669
pubmed: 19592406
Open Biol. 2019 Nov 29;9(11):190168
pubmed: 31744423
Epigenomics. 2019 May;11(6):577-579
pubmed: 31070049
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
Nutrients. 2021 Feb 10;13(2):
pubmed: 33578935
Scand Cardiovasc J. 2019 Apr;53(2):91-97
pubmed: 31109205
PLoS One. 2013 Aug 21;8(8):e70386
pubmed: 23990903
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):374-6
pubmed: 15854145
Brief Funct Genomics. 2016 Nov;15(6):460-469
pubmed: 27142121
Front Mol Biosci. 2021 Apr 09;8:645823
pubmed: 33898522
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
Nucleic Acids Res. 2007;35(22):7417-28
pubmed: 17913751
J Med Genet. 2020 Aug;57(8):571-580
pubmed: 32561571
Biomedicines. 2021 May 30;9(6):
pubmed: 34070760
J Hum Hypertens. 2002 Mar;16(3):147-50
pubmed: 11896501
Auton Neurosci. 2011 Feb 24;160(1-2):107-14
pubmed: 21183409
Psychosom Med. 1981 Aug;43(4):343-64
pubmed: 7280162
J Hypertens. 2001 Mar;19(3 Pt 2):529-33
pubmed: 11327625
PLoS Med. 2019 Feb 4;16(2):e1002741
pubmed: 30716101
Circulation. 2019 Sep 17;140(12):976-978
pubmed: 31525101
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
FASEB Bioadv. 2022 Mar 28;4(6):408-434
pubmed: 35664831
Circulation. 2003 Jan 7;107(1):139-46
pubmed: 12515756
Hypertens Res. 2011 Apr;34(4):431-40
pubmed: 21228777
Epigenomics. 2018 Feb;10(2):175-185
pubmed: 29336607
PLoS One. 2015 Mar 25;10(3):e0120032
pubmed: 25807557
FASEB J. 2018 May 29;:fj201800218RR
pubmed: 29812972
Int J Gen Med. 2021 Jul 23;14:3775-3785
pubmed: 34326663
Nucleic Acids Res. 2008 Jun;36(11):3667-75
pubmed: 18474527
Am J Hypertens. 2021 Apr 2;34(3):267-273
pubmed: 33821945
PLoS One. 2012;7(9):e45292
pubmed: 23028911
Nucleic Acids Res. 2008 Oct;36(17):5704-12
pubmed: 18776216
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):668-674
pubmed: 28655164
Hypertension. 2012 Nov;60(5):1117-23
pubmed: 23006731
Asian Pac J Cancer Prev. 2012;13(9):4469-75
pubmed: 23167363
Hypertension. 2018 Dec;72(6):1244-1254
pubmed: 30571238
Front Genet. 2021 Aug 26;12:693071
pubmed: 34512720
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847
Elife. 2021 Jan 29;10:
pubmed: 33512317
Nucleic Acids Res. 2021 Apr 6;49(6):3020-3032
pubmed: 33300031

Auteurs

Jirapan Thongsroy (J)

School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.

Apiwat Mutirangura (A)

Center of Excellence in Molecular Genetics of Cancer and Human Disease, Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH